Insulin glargine and lixisenatide Subcutaneous and Marvelon 21
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Marvelon 21 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: desogestrel / ethinyl estradiol
Brand name: Azurette, Cyclessa, Desogen, Isibloom, Kariva, Mircette, Reclipsen, Cyred
Synonyms: Ethinyl estradiol and desogestrel, Ethinyl Estradiol and Desogestrel
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Marvelon 28 - White Tablet
- Insulin glargine and lixisenatide Subcutaneous-Marvona SUIK
- Insulin glargine and lixisenatide Subcutaneous-Masanti Supreme
- Insulin glargine and lixisenatide Subcutaneous-Matulane
- Insulin glargine and lixisenatide Subcutaneous-Matzim LA
- Insulin glargine and lixisenatide Subcutaneous-Mavenclad
- Marvelon 21-Insulin glargine, recombinant Subcutaneous
- Marvelon 21-Insulin glulisine
- Marvelon 21-Insulin Glulisine (Cartridges and Pens)
- Marvelon 21-Insulin Glulisine (Vials)
- Marvelon 21-Insulin glulisine Subcutaneous
- Marvelon 21-Insulin human inhaled Inhalation